Syrentis Clinical Research to be a Major Sponsor at the 5th Annual Golden Future 50+ Expo Long Beach Edition
More than 10,000 baby boomers turn age 65 every day in this country, entering the age of risk for developing Alzheimer's. For over 20 years, Dr. John Gregory Duffy has witnessed the disturbing effects of this disease as both a physician and research scientist at Syrentis Clinical Research. Syrentis researchers have worked tirelessly to better understand the progression of this disease and to develop more successful treatments. Syrentis Clinic Research currently has several studies for Alzheimer's prevention, mild cognitive impairment, and Alzheimer's Dementia.
LONG BEACH, Calif., March 28, 2019 /PRNewswire-PRWeb/ -- Golden Future Expos Inc. (GFE) proudly announces that Syrentis Clinical Research based in Santa Ana, CA is the 2019 Gold Sponsor for the 5th Annual Golden Future 50+ Senior Expo Long Beach Edition which will take place on Saturday, March 30th 2019 from 10am – 2:30pm at the Best Western Golden Sails Hotel located at 6285 E. Pacific Coast Highway, Long Beach, CA 90803.
With over 40 years of experience in health care, Syrentis Clinical Research specializes in treating patients with Alzheimer's disease and strives to develop cutting edge treatments for dementia related illnesses.
Syrentis Clinical Research conducts clinical trials. Clinical trials are research studies that test medical strategies, treatments, and devices to ensure they are safe and effective for humans. Clinical trials follow strict scientific protocols which protect patients and produce reliable results. A clinical trial may improve patient outcomes, offer no benefit, or cause unexpected harm or side effects. All of these results are important because they advance medical knowledge.
After conducting over 600 Phase I-IV clinical trials, Syrentis Clinical Research has contributed to the development of treatments for many medical conditions with an emphasis in CNS disorders (Alzheimer's Dementia, Major Depressive Disorder, Bipolar Disorder, Anxiety Disorder, Insomnia) as well as Diabetes Mellitus, COPD, Peripheral Neuropathy, Cardiovascular Disease, Fibromyalgia, Hypercholesterolemia, Hypertension, Chronic Pain, Endocrine disorders, Metabolic Syndrome, Claudication, PVD, Birth Control, Dermatologic disorders, and new drug delivery systems including vaccines, inhalers, injections, and topical patch systems.
For more information, meet the Syrentis team in person on Saturday, March 30th at the Golden Future 50+ Expo or call them at 714-542-3008 or visit their website at http://www.syrentis.com.
SOURCE Golden Future Expos Inc.
Share this article